ICAM-4, a newly characterized adhesion molecule, is expressed early in human erythropoiesis and functions as a ligand for binding α 4 β 1 and α V integrin-expressing cells.
INTRODUCTION
During terminal erythroid differentiation a diverse array of cell adhesion proteins are expressed on the erythroblast surface [1] [2] [3] [4] [5] [6] [7] [8] [9] . These molecules mediate erythroblast interactions with both stromal cells and extracellular matrix fibronectin and laminin (reviewed in reference 10) .
Within the bone marrow microenvironment, developing erythroblasts surround a central macrophage forming substructures termed erythroblastic islands (or blood islands) [11] [12] [13] [14] .
Increasing evidence suggests that these islands are highly specialized bone marrow subcompartments where cell-cell adhesion events, in concert with cytokines, play critical roles in erythropoiesis and regulation of apoptosis.
ICAM-4 (also known as LW blood group glycoprotein) is a newly characterized adhesion molecule expressed on early human erythroblasts concurrently with glycophorin A and RhGP 9 .
Located on chromosome 19, the ICAM-4 gene contains 3 exons encoding a polypeptide which has a single membrane spanning domain, 6 cysteine residues and 4 potential N-glycosylation sites 15, 16 , two of which are glycosylated in expressed human protein (reference 17 and unpublished observations, Tosti Mankelow). Predicted membrane topology reveals two extracellular immunoglobulin-like domains (an N-terminal I set and a membrane proximal I2 set domain) which show very strong sequence homology (overall identity ~30%) with other members of the ICAM protein superfamily 15, 18 . Very recently it has been shown that ICAM-4 binds α 4 β 1 integrin on human hematopoietic cell lines and also α V -family integrins on α 4 β 1 -negative, non-hematopoietic cell lines 17 . Since erythroblasts express α 4 β 1 and macrophages exhibit α V , ICAM-4 is an attractive candidate for mediating cell-cell interactions within erythroblastic islands. There is also evidence that increased expression of ICAM-4 on sickle red blood cells may contribute to their abnormal adhesiveness 19, 20 . It therefore seems reasonable to postulate that this newly characterized integrin counterreceptor may function not only in cell-cell interactions during normal erythropoiesis but it may also contribute to the pathophysiology of 
MATERIALS AND METHODS
cDNA sequencing. Mouse EST clones (accession numbers AA050210, W98798 and W62001) that were closely related to human ICAM-4 were obtained from IMAGE Consortium (info@image.llnl.gov). Sequencing primers were sense and antisense vector primers, as well as sense and antisense mouse cDNA primers (5'-TCAATCTCGACGGGCTA-3' and 5'-CAAGGGGGCCTGCAGAA-3', respectively). DNA sequencing was performed using dyelabeled terminator chemistry on Applied Biosystems 373 or 373A automated DNA sequencers (Perkin Elmer, Foster City, CA, and Perkin Elmer, Warrington, UK, respectively). were coated with 1µg/well goat-anti-human-Fc Ig (Sigma) overnight at 4°C. They were then washed three times with PBS and incubated overnight at 4°C with chimeric proteins at specified concentrations in PBS. The following day they were washed three times with PBS, then blocked 
RESULTS

Cloning and characterization of mouse ICAM-4.
Three mouse EST clones more closely related to human ICAM-4 than to any other member of the human immunoglobulin superfamily were identified by scanning the GenBank database with human ICAM-4 protein sequence. The three clones contained overlapping DNA sequences.
Clones AA050210 and W98798 were sequenced and comprised the protein coding region and the 3' non-coding region of murine ICAM-4. Clone W62001 was partly sequenced to determine the 5' untranslated region. The putative organization of the murine gene was deduced by aligning 9 sequence of the human gene with sequences of murine EST clones. Surprisingly, murine EST clones contained intron 2 sequence in addition to exons 1, 2 and 3 (GenBank accession number AF296283). To determine whether ICAM-4 mRNA lacking intron 2 was also present, we screened a mouse spleen cDNA library by PCR using primers binding to the 3' end of exon 1 and the 3' end of exon 3. Two products of 594bp and 456bp were amplified (Figure 1 ). Sequencing revealed that the larger one contained intron 2 while the smaller one lacked intron 2 (GenBank accession number AF296282). We therefore concluded that there are two ICAM-4 mRNA species in mouse. Since the 139bp intron 2 has a stop codon at 111, we predicted that exon 3 sequence would not be translated from mRNA containing intron 2.
To clone the murine ICAM-4 gene, the high-throughput sequence database of NCBI was splice acceptor ag motifs were present in all of the intron/exon boundary sequences ( Table 1 ).
The three exonic sequences derived from our genomic sequence were completely homologous with the sequence of ICAM-4 cDNA derived from EST clones. Binding motifs for erythroid transcription factors GATA 1 and SP 1 were identified 73nt and 38nt upstream of the initiation codon, respectively. Organization and size of the murine gene was very similar to that of its human counterpart, which also contains three exons distributed over 2.65Kb 16 . Figure   3B ). HEL cells also express integrin subunits β 3 , α 2 , α 5 and α V 17 . However, blocking antibodies to these four integrin subunits had no effect on binding of HEL cells to either human or murine ICAM-4 ( Figure 3B ).
Human ICAM-4 is unusual in that it has a second counterreceptor, α V , that is widely expressed on non-hematopoietic cells 17 . Because erythroblasts interact with macrophages within the bone marrow microenvironment and macrophages exhibit α V integrins on their surface, we were interested to test adherence of α V -expressing cells to mouse ICAM-4. We discovered that 
Amino acid sequence comparisons of mouse ICAM-4 isoforms.
When the translated amino acid sequences of the two mouse ICAM-4 mRNAs (one with and one without intron 2) were analyzed we found that both isoforms are 261 amino acids in length ( Figure 4 ). Amino acid residues 1-224, which constitute the extracellular domain, are identical.
The polypeptide translated from cDNA containing intron 2 terminates at a stop codon TAG (nt 787-789) within intron 2, and therefore does not contain the transmembrane and cytoplasmic domain sequences encoded by exon 3. Interestingly, however, in the polypeptide translated from cDNA containing intron 2, much of the hydrophobic sequence in the putative transmembrane domain of the prototypical ICAM-4 is replaced by hydrophilic residues encoded by intron 2. We, therefore, speculated that this ICAM-4 isoform might be secreted, and will henceforth refer to it as ICAM-4S.
Erythroblasts express two isoforms of ICAM-4.
To determine whether ICAM-4S mRNA is expressed in differentiating erythroblasts, we analyzed mRNA isolated from proerythrobasts obtained from Friend virus-infected mice (FVA cells). This carefully characterized model system of terminal erythroid differentiation closely mimics in vivo erythropoiesis 23, [27] [28] [29] [30] [31] [32] Using primers binding to exon 1 and exon 3, products of 594bp and 456bp were amplified by PCR ( Figure 5 ). These products correspond to the predicted sizes of the two ICAM-4 isoforms, thereby demonstrating that erythroblasts do, indeed, express both isoforms. To explore whether a developmentally regulated change in isoform expression occurs during terminal differentiation, we compared RT/PCR products amplified from mRNA of 
ICAM-4S is secreted.
To study whether mRNA containing intron 2 is effectively translated and, if so, whether the Figure 7B ). We conclude from these data that 14 mRNA containing intron 2 is effectively translated and that the resulting polypeptide is a secreted isoform of ICAM-4.
DISCUSSION
A major finding of the current study is that there is a secreted isoform of ICAM-4. In several EST clones and a mouse spleen cDNA library we discovered a distinct mRNA species containing intron 2 sequence. This mRNA would be predicted to encode an ICAM-4 isoform lacking a hydrophobic transmembrane spanning domain. Consistent with this prediction, immunofluorescence microscopy of COS-7 cells transfected with GFP constructs of ICAM-4 cDNAs +/-intron 2 sequence showed that the fusion protein translated from cDNA lacking intron 2 localized to plasma membranes of transfected cells, while the isoform expressed from the construct containing intron 2 was detected as discrete cytoplasmic foci. Moreover, the isoform expressed from the construct containing intron 2 was secreted into the tissue culture medium of transfected cells. On this basis we have termed the secreted form of ICAM-4, ICAM-4S. Interestingly, Cartron and colleagues isolated a similar clone from a human bone marrow cDNA library, although they have not reported whether the encoded human protein is secreted 15 .
We postulate that secretion of ICAM-4S may modulate binding interactions of ICAM-4 and could thus play a critical regulatory role in erythroblast adhesion.
Our observations of the developmental timeframe of ICAM-4S mRNA expression suggest that this isoform's regulatory role occurs late in erythropoiesis. We found an upregulation of ICAM-4S mRNA late in the terminal differentiation of mouse erythroblasts. We postulate that 
